How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action
如何在药品监管评估中运用和传达患者偏好?IMI PREFER 的研究结果和建议以及行动呼吁
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1192770
Janssens, Rosanne; Barbier, Liese; Muller, Mireille; Cleemput, Irina; Stoeckert, Isabelle; Whichello, Chiara; Levitan, Bennett; Hammad, Tarek A; Girvalaki, Charis; Ventura, Juan-Jose; Bywall, Karin Schölin; Pinto, Cathy Anne; Schoefs, Elise; Katz, Eva G; Kihlbom, Ulrik; Huys, Isabelle